Clinical Trials Browser

Anatomic Stage IV Breast Cancer AJCC v8

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Lung Neoplasms, Motor Activity

Glioblastoma

Rectal Neoplasms

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

Lymphoma, Extranodal NK-T-Cell

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Squamous Cell Carcinoma of Head and Neck

Breast Neoplasms, Triple Negative Breast Neoplasms

Spinal Cord Neoplasms

Arthritis, Joint Diseases

Rectal Neoplasms

Uterine Cervical Neoplasms

Rhabdomyosarcoma

Colorectal Neoplasms

Cervical Cancer by FIGO Stage 2018

Glioblastoma

Breast Neoplasms, Triple Negative Breast Neoplasms

Squamous Cell Carcinoma of Head and Neck

Prostatic Neoplasms

Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Esophageal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Rectal Cancer Patients

Carcinoma, Hepatocellular

Non-Muscle Invasive Bladder Neoplasms

Glioblastoma

Digestive System Neoplasms

Brain Neoplasms, Breast Neoplasms, Meningeal Carcinomatosis

Oropharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Rectal Neoplasms

Nasopharyngeal Carcinoma

Head and Neck Neoplasms, Pelvic Neoplasms, Radiation Injuries

Adenocarcinoma

Clinical Trials

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

Hypofractionated Chemoradiotherapy With Tislelizumab and Surufatinib for Unresectable Stage III NSCLC

CURB-TKI

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

Radiation Treatment of the Prostate That is Specially Adjusted for Each Person

SPRINT 2

PReFACe

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

ACO/ARO/AIO-22

ZAMBONI

Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma

ABCD RT

RAIN-HNSCC

ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation

The Effect of Radiotherapy After Separation Surgery for Spinal Metastases

Radiation to Treat Joint Damage Caused by Cancer Immunotherapy

NG-ST

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)

TRIUNITE-07

RETHEMCOL

INSIGHT MRL

PH Weighted Chemical Exchange Saturation Transfer MRI-Based Surgical Resection to Improve Survival in Patients With Glioblastoma

NoCUT-BC

Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases

A Single-arm, Phase II, Multi-center Clinical Trial of Sintilimab During the Perioperative Period in Patients With Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

SENTRY

A Study of Bemotuzumab Plus Chemotherapy and Anlotinib Induction Followed by Bemotuzumab, Anlotinib and Consolidative Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer

Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC

Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer

Prospective Comparative Study of Hypofractionated Adjuvant Radiotherapy in 2 Virsus 3 Weeks in Breast Cancer

Spirulina Derivative for Radiation Esophagitis

Neo-Margin

Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

Radiotherapy Plus CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as Neoadjuvant Therapy for LARC

Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma

TRAIN

NG101m Adjuvant Therapy in Glioblastoma Patients

A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.

TAS-102 Plus Radiotherapy in Elderly ESCC

IP rmhTNF-NC + Tislelizumab + Palliat RT for GIT Tumor Malignant Ascites After Failed Std Tx

A Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain Metastases

Evaluating a Decreased Dose of Radiation Therapy to the Elective Neck for the Treatment of HPV-Related Oropharyngeal Cancer, ENLIGHT Trial

[18F]-AraG PET Imaging in LA HNSCC

STAR

DECIDING

Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

HOPE

NACRE-2